1,316
Views
28
CrossRef citations to date
0
Altmetric
REVIEW

Review: Clinical Inertia in the Management of Chronic Obstructive Pulmonary Disease

, , &
Pages 73-80 | Published online: 31 Jan 2012

References

  • Miniño AM, Xu JQ, Kochanek KD. Deaths: Preliminary Data for 2008. National Vital Statistics Reports; vol 59 no 2. Hyattsville, MD: National Center for Health Statistics. 2010. Available at: www.cdc.gov/nchs/data/nvsr/nvsr59/nvsr59_02.pdf. Accessed September 30, 2011.
  • Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease (Updated 2010). Available at: http://www.goldcopd.org/uploads/users/files/GOLDReport_April112011.pdf. Accessed September 30, 2011.
  • Celli B, MacNee W; ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004; 23(6):932–946.
  • Mularski RA, Asch SM, Shrank WH, Kerr EA, Setodji CM, Adams JL, Keesey J, McGlynn EA. The quality of obstructive lung disease care for adults in the United States a measured by adherence to recommended processes. Chest 2006; 130(6):1844–1850.
  • Diette GB, Orr P, McCormack MC, Gandy W, Hamar B. Is pharmacologic care of chronic obstructive pulmonary disease consistent with the guidelines? Popul Health Manag 2010; 13(1):21–26.
  • Phillips LS, Branch WT, Cook CB, Doyle JP, El-Kebbi IM, Gallina DL, Miller CD, Ziemer DC, Barnes CS. Clinical inertia. Ann Intern Med 2001; 135(9):825–834.
  • Allen JD, Curtiss FR, Fairman KA. Nonadherence, clinical inertia, or therapeutic inertia? J Manag Care Pharm 2009; 15(8):690–695.
  • Safford MM, Shewchuk R, Qu H, Williams JH, Estrada CA, Ovalle F, Allison JJ. Reasons for not intensifying medications: differentiating “clinical inertia” from appropriate care. J Gen Intern Med 2007; 22(12):1648–1655.
  • Ramsey SD. Suboptimal medical therapy in COPD: exploring the causes and consequences. Chest 2000;117(2 Suppl):33S–37S.
  • Heins-Nesvold J, Carlson A, King-Schultz L, Joslyn KE. Patient identified needs for chronic obstructive pulmonary disease versus billed services for care received. Int J Chron Obstruct Pulmon Dis 2008; 3(3):415–421.
  • Nesvold JH, Carlson A, Yawn B, Joslyn K. What are you doing for the 76 patients with COPD in your practice? Minn Med 2008; 91(10):45–46.
  • Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance –United States, 1971–2000. MMWR Surveill Summ 2002; 51(6):1–16.
  • Yawn B, Mannino D, Littlejohn T, Ruoff G, Emmett A, Raphiou I, Crater G. Prevalence of COPD among symptomatic patients in a primary care setting. Curr Med Res Opin 2009; 25(11):2671–2677.
  • Joo MH, Au DH, Lee TA. Use of spirometry in the diagnosis of chronic obstructive pulmonary disease and efforts to improve quality of care. Transl Res 2009; 154(3):103–110.
  • Kaminsky DA, Marcy TW, Bachand M, Irvin CG. Knowledge and use of office spirometry for the detection of chronic obstructive pulmonary disease by primary care physicians. Respir Care 2005; 50(12):1639–1648.
  • Moore PL. Practice management and chronic obstructive pulmonary disease in primary care. Am J Med 2007; 120(8 suppl 1):S23–S27.
  • Lee TA, Bartle B, Weiss KB. Spirometry use in clinical practice following diagnosis of COPD. Chest 2006; 129:1509–1515.
  • Joo MJ, Lee TA, Au DH, Fitzgibbon ML, Weiss KB. Medication use patterns associated with spirometry in diagnosing COPD. COPD 2008; 5(6):360–368.
  • Chavez PC, Shokar NK. Diagnosis and management of chronic obstructive pulmonary disease (COPD) in a primary care clinic. COPD 2009; 6(6):446–451.
  • Han MK, Kim MG, Mardon R, Renner P, Sullivan S, Diette GB, Martinez FJ. Spirometry utilization for COPD: how do we measure up? Chest 2007; 132(2):403–409.
  • Yawn BP, Enright PL, Lemanskie RF Jr, Israel E, Pace W, Wollan P, Boushey H. Spirometry can be done in family physicians’ offices and alters clinical decisions in the management of asthma and COPD. Chest 2007; 132(4):1162–1168.
  • U.S. Preventive Services Task Force. Screening for chronic obstructive pulmonary disease using spirometry: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2008; 148(7):529–534.
  • Yawn BP, Mapel DW, Mannino DM, Martinez FJ, Donohue JF, Hanania NA, Kosinski M, Rendas-Baum R, Mintz M, Samuels S, Dalal AA; Lung Function Questionnaire Working Group. Development of the Lung Function Questionnaire (LFQ) to identify airflow obstruction. Int J Chron Obstruct Pulmon Dis 2010; 5:1–10.
  • Hanania NA, Mannino DM, Yawn BP, Mapel DW, Martinez FJ, Donohue JF, Kosinski M, Rendas-Baum R, Mintz M, Samuels S, Jhingran P, Dalal AA. Predicting risk of airflow obstruction in primary care: Validation of the lung function questionnaire (LFQ). Respir Med 2010; 104(8):1160–1170.
  • Cokkinides VE, Halpern MT, Barbeau EM, Ward E, Thun MJ. Racial and ethnic disparities in smoking-cessation interventions: analysis of the 2005 National Health Interview Survey. Am J Prev Med 2008 May; 34(5):404–412.
  • Lee TA, Weaver FM, Weiss KB. Impact of pneumococcal vaccination on pneumonia rates in patients with COPD and asthma. J Gen Intern Med 2007; 22(1):62–67.
  • Craig BM, Kraus CK, Chewning BA, Davis JE. Quality of care for older adults with chronic obstructive pulmonary disease and asthma based on comparisons to practice guidelines and smoking status. BMC Health Serv Res 2008; 8:144.
  • Barr RG, Celli BR, Martinez FJ, Ries AL, Rennard SI, Reilly JJ Jr, Sciurba FC, Thomashow BM, Wise RA. Physician and patient perceptions in COPD: the COPD Resource Network Needs Assessment Survey. Am J Med 2005 Dec; 118(12):1415.
  • Yawn BP, Wollan PC. Knowledge and attitudes of family physicians coming to COPD continuing medical education. Int J Chron Obstruct Pulmon Dis 2008; 3(2):311–317.
  • Foster JA, Yawn BP, Maziar A, Jenkins T, Rennard SI, Casebeer L. Enhancing COPD management in primary care settings. MedGenMed 2007; 9(3):24.
  • Petty TL. Benefits of and barriers to the widespread use of spirometry. Curr Opin Pulm Med 2005; 11(2):115–120.
  • Jung E, Pickard AS, Salmon JW, Bartle B, Lee TA. Medication adherence and persistence in the last year of life in COPD patients. Respir Med 2009; 103(4):525–534.
  • Joo MJ, Lee TA, Weiss KB. Geographic variation of spirometry use in newly diagnosed COPD. Chest 2008; 134:38–45.
  • Restrepo RD, Alvarez MT, Wittnebel LD, Sorenson H, Wettstein R, Vines DL, Sikkema-Ortiz J, Gardner DD, Wilkins RL. Medication adherence issues in patients treated for COPD. Int J Chron Obstruct Pulmon Dis 2008; 3(3):371–384.
  • Barr RG, Celli BR, Mannino DM. Comorbidities, patient knowledge, and disease management in national sample of patients with COPD. Am J Med 2009; 122(4):348–355.
  • Rennard S, Decramer M, Calverly PM, Pride NB, Soriano JB, Vermeire PA, Vestbo J. Impact of COPD in North America and Europe in 2000: subjects’ perspective of confronting COPD international survey. Eur Respir J 2002; 20(4):799–805.
  • Heffner JE, Ellis R. The guideline approach to chronic obstructive pulmonary disease: how effective? Respir Care 2003; 48(12):1257–1266.
  • Ward MM, Yankey JW, Vaughn TE, BootsMiller BJ, Flach SD, Watrin S, Doebbeling BN. Provider adherence to COPD guidelines: relationship to organizational factors. J Eval Clin Pract 2005; 11(4):379–387.
  • Nelson M, Hamilton HE. Improving in-office discussion of chronic obstructive pulmonary disease: results and recommendations from an in-office linguistic study in chronic obstructive pulmonary disease. Am J Med 2007; 120(8 Suppl 1):S28–S32.
  • Han MK. Medication adherence in COPD: what have we learned? Thorax 2009 Nov; 64(11):922–923.
  • Davis D, O'Brien MA, Freemantle N, Wolf FM, Mazmanian P, Taylor-Vaisey A. Impact of formal continuing medical education: do conferences, workshops, rounds, and other traditional continuing education activities change physician behavior or health care outcomes? JAMA 1999; 282(9):867–874.
  • Davis DA, Thomson MA, Oxman AD, Haynes RB. Changing physician performance. A systematic review of the effect of continuing medical education strategies. JAMA 1995 6; 274(9):700–705.
  • Flanagan ME, Ramanujam R, Doebbeling BN. The effect of provider- and workflow-focused strategies for guideline implementation on provider acceptance. Implement Sci 2009; 4:71.
  • Kuilboer MM, van Wijk MA, Mosseveld M, van der Does E, de Jongste JC, Overbeek SE, Ponsioen B, van der Lei J. Computed critiquing integrated into daily clinical practice affects physicians’ behavior- a randomized clinical trial with AsthmaCritic. Methods Inf Med 2006; 45(4):447–454.
  • Tierney WM, Overhage JM, Murray MD, Harris LE, Zhou XH, Eckert GJ, Smith FE, Nienaber N, McDonald CJ, Wolinsky FD. Can computer-generated evidence-based care suggestions enhance evidence-based management of asthma and chronic obstructive pulmonary disease? A randomized, controlled trial. Health Serv Res 2005; 40(2):477–497.
  • Solomon DK, Portner TS, Bass GE, Gourley DR, Gourley GA, Holt JM, Wicke WR, Braden RL, Eberle TN, Self TH, Lawrence BL. Clinical and economic outcomes in hypertension and COPD arms of a multicenter outcomes study. J Am Pharm Assoc (Wash) 1998; 38(5):574–585.
  • Rickles NM, Brown TA, McGivney MS, Snyder ME, White KA. Adherence: a review of education, research, practice, and policy in the United States. Pharmacy Practice (Internet) 2010; 8(1):1–17. Available at: http://www.pharmacypractice.org/vol08/pdf/001–017.pdf. Accessed September 30, 2011.
  • Effing T, Monninkhof EM, van der Valk PD, van der Palen J, van Herwaarden CL, Partidge MR, Walters EH, Zielhuis GA. Self-management education for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2007 Oct 17; (4):CD002990.
  • Niesink A, Trappenburg JC, de Weert-van Oene GH, Lammers JW, Verheij TJ, Schrijvers AJ. Systematic review of the effects of chronic disease management on quality-of-life in people with chronic obstructive pulmonary disease. Respir Med 2007; 101(11):2233–2239.
  • Centers for MediCare & MediCaid Services. Roadmap for quality measurement in the traditional medicare fee-for-service program. Available at: http://www.cms.gov/QualityInitiativesGenInfo/downloads/QualityMeasurement Roadmap_OEA1–16_508.pdf Accessed September 30, 2011.
  • Fallon Community Health Plan. 2011 HEDIS measures. Available at: http://www.fchp.org/providers/resources/hedis-measures.aspx. Accessed September 30, 2011.
  • Heffner JE, Mularski RA, Calverly PM. COPD performance measures: missing opportunities for improving care. Chest; Prepublished online March 26, 2010. DOI 10.1378/chest.09–2306. Available at: http://chestjournal.chestpubs.org/content/early/2010/03/24/chest.09–2306. Accessed September 30, 2011.
  • Roberts DH, Gilmartin GS, Neeman N, Schulze JE, Cannistraro S, Ngo LH, Aronson MD, Weiss JW. Design and measurement of quality improvement indicators in ambulatory pulmonary care: creating a “culture of quality” in an academic pulmonary division. Chest 2009; 136(4):1134–1140.
  • COPD Alliance. COPD Population Screener (COPD-PS). Available at: http://copd.org/sites/default/files/COPD-Screener.pdf. Accessed September 30, 2011.
  • Centers for Medicare & Medicaid Services (CMS). Physician Quality Reporting System Overview. Available at: http://www.cms.gov/PQRS/01_Overview.asp#TopOfPage. Accessed September 30, 2011.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.